Delivery Order SPE2DB22D3016-SPE2DB25FAQX9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,123.41 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a synthetic progestin used in hormone therapy and contraceptive applications. This firm fixed-price contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical. The contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.15 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone-based pharmaceutical product. This non-competitive delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $1,003.18 delivery order to AmerisourceBergen Drug Corp for medroxyprogesterone on September 13, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement executed under the company's existing contract vehicle. The work will be performed at the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,839.57 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/ml. This competitive award, issued on September 4, 2025, carries a firm fixed price structure with performance completion targeted for September 5, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,140.26 firm fixed-price delivery order is for the supply of medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $1,562.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,212,074 milliliters of medroxyprogesterone 150 mg/ml, a medication, with an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,495.01 to AmerisourceBergen Drug Corp for Medroxyprogesterone 150 mg/mL, a progestin medication used in hormone replacement therapy and contraceptive applications. The contract, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries a firm fixed price and represents a non-competitive delivery order. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $12,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 150 mg/ml medroxyprogesterone. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day contract spanning August 24-25, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a $1,253.23 delivery order to AmerisourceBergen Drug Corp for Medroxyprogesterone 150 mg/mL, a hormone treatment medication. This non-set-aside, competitively awarded contract was executed on September 10, 2025, with an ultimate completion date of September 11, 2025, and is classified as a firm fixed price delivery order. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone treatment medication, valued at $7,627.72 under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and serves as a...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAQX9Delivery Order
The Defense Logistics Agency awarded a $1,562.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on March 11, 2025, for the supply of Medroxyprogesterone 150 mg/ml with an ultimate completion date of March 12, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical products and medical supplies. The parent IDC contract functions as a global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the routine pharmaceutical procurement operations under that master contract vehicle, supporting the Department of Defense's medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 3/11/25 |